Ectopic bone formation in severely combat-injured orthopedic patients - A hematopoietic niche

Bone

Volumn 56, Issue 1, 2013, Pages 119-126

  Davis, Thomas A ^a,c   Lazdun, Yelena ^a   Potter, Benjamin K ^b,c   Forsberg, Jonathan A ^a,b,c  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Ectopic bone; Extremity injuries; Hematopoiesis; Hematopoietic niche; Heterotopic ossification

Indexed keywords

ADIPOGENESIS; ADULT; AMPUTATION; ARTICLE; BATTLE INJURY; BLEEDING; BONE MARROW; BONE MARROW CELL; BONE MATURATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; ECTOPIC BONE; ECTOPIC ORGAN; ERYTHROID CELL; EXTRAMEDULLARY HEMATOPOIESIS; GRANULATION TISSUE; HEMATOPOIETIC CELL; HETEROTOPIC OSSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INJURY SEVERITY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MORBIDITY; MUSCLE INJURY; TRABECULAR BONE; VASCULARIZATION; WOUND HEALING;

ACL; ANTERIOR CRUCIATE LIGAMENT; BFU-E; BURST FORMING UNIT-ERYTHROID; CFC; CFU; CFU-GEMM; CFU-GM; CFU-M; COLONY FORMING UNIT; COLONY FORMING UNIT-GRANULOCYTE AND MACROPHAGE; COLONY FORMING UNIT-MACROPHAGE; COLONY-FORMING CELL; ECTOPIC BONE; ECTOPIC INTRAMEDULLARY HEMATOPOIESIS; EIH; EMH; EXTRAMEDULLARY HEMATOPOIESIS; EXTREMITY INJURIES; HEMATOPOIESIS; HEMATOPOIETIC NICHE; HEMATOPOIETIC PROGENITOR CELL; HETEROTOPIC OSSIFICATION; HO; HPC; INJURY SEVERITY SCORE; ISS; MATRIX METALLOPROTEINASE; MESENCHYMAL STEM CELL; MMP; MSC; MULTILINEAGE COLONY FORMING UNIT-GRANULOCYTE, MACROPHAGE AND MEGAKARYOCYTE; PHSC; PLURIPOTENT HEMATOPOIETIC STEM CELLS;

ADOLESCENT; ADULT; COLONY-FORMING UNITS ASSAY; DEMOGRAPHY; HEMATOPOIETIC STEM CELLS; HUMANS; IMAGING, THREE-DIMENSIONAL; ORTHOPEDICS; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS; STEM CELL NICHE; TOMOGRAPHY, X-RAY COMPUTED; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84879337401     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.05.016     Document Type: Article

References (60)

1. Brown K.V., Dharm-Datta S., Potter B.K., Etherington J., Mistlin A., Hsu J.R., et al. Comparison of development of heterotopic ossification in injured US and UK Armed Services personnel with combat-related amputations: preliminary findings and hypotheses regarding causality. J Trauma 2010, 69(Suppl. 1):S116-S122.
2. Forsberg J.A., Potter B.K. Heterotopic ossification in wartime wounds. J Surg Orthop Adv 2010, 19:54-61.
3. Potter B.K., Burns T.C., Lacap A.P., Granville R.R., Gajewski D. Heterotopic ossification in the residual limbs of traumatic and combat-related amputees. J Am Acad Orthop Surg 2006, 14:S191-S197.
4. Potter B.K., Burns T.C., Lacap A.P., Granville R.R., Gajewski D.A. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am 2007, 89:476-486.
5. Potter B.K., Forsberg J.A., Davis T.A., Evans K.N., Hawksworth J.S., Tadaki D., et al. Heterotopic ossification following combat-related trauma. J Bone Joint Surg Am 2010, 92(Suppl. 2):74-89.
6. Forsberg J.A., Pepek J.M., Wagner S., Wilson K., Flint J., Andersen R.C., et al. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am 2009, 91:1084-1091.
7. Moore K.D., Goss K., Anglen J.O. Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. J Bone Joint Surg Br 1998, 80:259-263.
8. Tintle S.M., Forsberg J.A., Keeling J.J., Shawen S.B., Potter B.K. Lower extremity combat-related amputations. J Surg Orthop Adv 2010, 19:35-43.
9. Kaplan F.S., Glaser D.L., Hebela N., Shore E.M. Heterotopic ossification. J Am Acad Orthop Surg 2004, 12:116-125.
10. Kaplan F.S., Shore E.M. Derailing heterotopic ossification and RARing to go. Nat Med 2011, 17:420-421.
11. Chen Y., Whetstone H.C., Youn A., Nadesan P., Chow E.C., Lin A.C., et al. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 2007, 282:526-533.
12. Kaplan F.S., Hahn G.V., Zasloff M.A. Heterotopic ossification: two rare forms and what they can teach us. J Am Acad Orthop Surg 1994, 2:288-296.
13. Monroe D.G., McGee-Lawrence M.E., Oursler M.J., Westendorf J.J. Update on Wnt signaling in bone cell biology and bone disease. Gene 2012, 492:1-18.
14. Medici D., Shore E.M., Lounev V.Y., Kaplan F.S., Kalluri R., Olsen B.R. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010, 16:1400-1406.
15. Salisbury E., Rodenberg E., Sonnet C., Hipp J., Gannon F.H., Vadakkan T.J., et al. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem 2011, 112:2748-2758.
16. Davis T.A., O'Brien F.P., Anam K., Grijalva S., Potter B.K., Elster E.A. Heterotopic ossification in complex orthopaedic combat wounds: quantification and characterization of osteogenic precursor cell activity in traumatized muscle. J Bone Joint Surg Am 2011, 93:1122-1131.
17. Jackson W.M., Aragon A.B., Bulken-Hoover J.D., Nesti L.J., Tuan R.S. Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res 2009, 27:1645-1651.
18. Evans K.N., Forsberg J.A., Potter B.K., Hawksworth J.S., Brown T.S., Andersen R., et al. Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high-energy penetrating war injuries. J Orthop Trauma 2012, 26:e204-e213.
19. Cumano A., Godin I. Ontogeny of the hematopoietic system. Annu Rev Immunol 2007, 25:745-785.
20. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
21. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
22. Mikkola H.K., Orkin S.H. The journey of developing hematopoietic stem cells. Development 2006, 133:3733-3744.
23. Weissman I.L. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000, 100:157-168.
24. Li T., Wu Y. Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche. Bone Marrow Res 2011, 2011:353878.
25. Johns J.L., Christopher M.M. Extramedullary hematopoiesis: a new look at the underlying stem cell niche, theories of development, and occurrence in animals. Vet Pathol 2012, 49:508-523.
26. Kim C.H. Homeostatic and pathogenic extramedullary hematopoiesis. J. Blood Med. 2010, 1:13-19.
27. Eskazan A.E., Ar M.C., Baslar Z. Intracranial extramedullary hematopoiesis in patients with thalassemia: a case report and review of the literature. Transfusion 2012, 52:1715-1720.
28. Hawksworth J.S., Stojadinovic A., Gage F.A., Tadaki D.K., Perdue P.W., Forsberg J., et al. Inflammatory biomarkers in combat wound healing. Ann Surg 2009, 250:1002-1007.
29. Melcer T., Walker G.J., Sechriest V.F., Galarneau M., Konoske P., Pyo J. Short-term physical and mental health outcomes for combat amputee and nonamputee extremity injury patients. J Orthop Trauma 2013, 27:e31-e37.
30. Melcer T., Walker G.J., Galarneau M., Belnap B., Konoske P. Midterm health and personnel outcomes of recent combat amputees. Mil Med 2010, 175:147-154.
31. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 2008, 40:46-62.
32. Mackie E.J., Tatarczuch L., Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol 2011, 211:109-121.
33. Maes C., Carmeliet P., Moermans K., Stockmans I., Smets N., Collen D., et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 2002, 111:61-73.
34. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
35. Kiel M.J., Morrison S.J. Maintaining hematopoietic stem cells in the vascular niche. Immunity 2006, 25:862-864.
36. Garrett R.W., Emerson S.G. Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches. Cell Stem Cell 2009, 4:503-506.
37. Fuchs E., Tumbar T., Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004, 116:769-778.
38. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
39. Shiozawa Y., Taichman R.S. Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche. Exp Hematol 2012, 40:685-694.
40. Ding L., Saunders T.L., Enikolopov G., Morrison S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481:457-462.
41. Scotti C., Tonnarelli B., Papadimitropoulos A., Scherberich A., Schaeren S., Schauerte A., et al. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A 2010, 107:7251-7256.
42. Winkler I.G., Levesque J.P. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 2006, 34:996-1009.
43. Sanders R.L. Bone formation in upper abdominal scars. Ann Surg 1955, 141:621-626.
44. Christofi T., Raptis D.A., Kallis A., Ambasakoor F. True trilineage haematopoiesis in excised heterotopic ossification from a laparotomy scar: report of a case and literature review. Ann R Coll Surg Engl 2008, 90:W12-W14.
45. Lehrman A., Pratt J.H., Parkhill E.M. Heterotopic bone in laparotomy scars. Am J Surg 1962, 104:591-596.
46. Davis T.A., Robinson D.H., Lee K.P., Kessler S.W. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors. Blood 1995, 85:1751-1761.
47. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007, 213:341-347.
48. Eliasson P., Jonsson J.I. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 2010, 222:17-22.
49. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
50. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005, 201:1307-1318.
51. Miura Y., Gao Z., Miura M., Seo B.M., Sonoyama W., Chen W., et al. Mesenchymal stem cell-organized bone marrow elements: an alternative hematopoietic progenitor resource. Stem Cells 2006, 24:2428-2436.
52. Krebsbach P.H., Kuznetsov S.A., Satomura K., Emmons R.V., Rowe D.W., Robey P.G. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997, 63:1059-1069.
53. Kyoizumi S., Baum C.M., Kaneshima H., McCune J.M., Yee E.J., Namikawa R. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992, 79:1704-1711.
54. Maniatis A., Tavassoli M., Crosby W.H. Factors affecting the conversion of yellow to red marrow. Blood 1971, 37:581-586.
55. Mishima S., Nagai A., Abdullah S., Matsuda C., Taketani T., Kumakura S., et al. Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent. Eur J Haematol 2010, 84:538-546.
56. Sugimura R., He X.C., Venkatraman A., Arai F., Box A., Semerad C., et al. Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 2012, 150:351-365.
57. Iwata M., Awaya N., Graf L., Kahl C., Torok-Storb B. Human marrow stromal cells activate monocytes to secrete osteopontin, which down-regulates Notch1 gene expression in CD34+ cells. Blood 2004, 103:4496-4502.
58. Gimble J.M., Robinson C.E., Wu X., Kelly K.A. The function of adipocytes in the bone marrow stroma: an update. Bone 1996, 19:421-428.
59. Kricun M.E. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skelet Radiol 1985, 14:10-19.
60. Majumdar M.K., Thiede M.A., Haynesworth S.E., Bruder S.P., Gerson S.L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000, 9:841-848.